Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$24.32
At close: Aug 7 EDT
$24.32
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Couchbase Analyst Ratings and Price Targets | NASDAQ:BASE | Benzinga
Couchbase Inc has a consensus price target of $22.53 based on the ratings of 17 analysts. The high is $26 issued by Guggenheim on February 26, 2025. The low is $16 issued by Goldman Sachs on February 27, 2025. The 3 most-recent analyst ratings were released by Stifel, Truist Securities, and Baird on June 24, 2025, June 23, 2025, and June 23, 2025, respectively. With an average price target of $24.67 between Stifel, Truist Securities, and Baird, there's an implied 1.43% upside for Couchbase Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Stifel
Truist Securities
Baird
Rosenblatt
Needham
1calculated from analyst ratings
Analyst Ratings for Couchbase
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
06/24/2025 | 0.74% | Stifel | $22 → $24.5 | Downgrade | Buy → Hold | |||
06/23/2025 | 0.74% | Truist Securities | $21 → $24.5 | Downgrade | Buy → Hold | |||
06/23/2025 | 2.8% | Baird | $22 → $25 | Downgrade | Outperform → Neutral | |||
06/20/2025 | 0.74% | Rosenblatt | $22 → $24.5 | Downgrade | Buy → Neutral | |||
06/20/2025 | -9.54% | Needham | $22 → $22 | Downgrade | Buy → Hold | |||
06/20/2025 | 0.74% | Piper Sandler | $20 → $24.5 | Downgrade | Overweight → Neutral | |||
06/20/2025 | 0.74% | Wells Fargo | $20 → $24.5 | Downgrade | Overweight → Equal-Weight | |||
06/20/2025 | — | William Blair | — | Downgrade | Outperform → Market Perform | |||
06/20/2025 | 0.74% | Barclays | $22 → $24.5 | Maintains | Overweight | |||
06/20/2025 | 0.74% | DA Davidson | $25 → $24.5 | Downgrade | Buy → Neutral | |||
06/04/2025 | -21.88% | Morgan Stanley | $18 → $19 | Maintains | Equal-Weight | |||
06/04/2025 | -9.54% | RBC Capital | $22 → $22 | Reiterates | Outperform → Outperform | |||
06/04/2025 | -17.76% | UBS | $18 → $20 | Maintains | Neutral | |||
06/04/2025 | -9.54% | Baird | $20 → $22 | Maintains | Outperform | |||
06/04/2025 | -9.54% | Rosenblatt | $20 → $22 | Maintains | Buy | |||
06/04/2025 | -9.54% | Needham | $22 → $22 | Reiterates | Buy → Buy | |||
06/04/2025 | -17.76% | Piper Sandler | $16 → $20 | Maintains | Overweight | |||
06/02/2025 | -17.76% | Rosenblatt | $20 → $20 | Maintains | Buy | |||
04/23/2025 | -34.21% | Piper Sandler | $22 → $16 | Maintains | Overweight | |||
04/16/2025 | -25.99% | Morgan Stanley | $23 → $18 | Maintains | Equal-Weight | |||
04/09/2025 | -17.76% | Rosenblatt | → $20 | Initiates | → Buy | |||
02/27/2025 | -34.21% | Goldman Sachs | $18 → $16 | Maintains | Sell | |||
02/26/2025 | -25.99% | UBS | $19 → $18 | Maintains | Neutral | |||
02/26/2025 | -9.54% | RBC Capital | $25 → $22 | Maintains | Outperform | |||
02/26/2025 | 6.91% | Guggenheim | $30 → $26 | Maintains | Buy | |||
02/26/2025 | -5.43% | Morgan Stanley | $25 → $23 | Maintains | Equal-Weight | |||
02/26/2025 | -17.76% | Wells Fargo | $23 → $20 | Maintains | Overweight | |||
02/26/2025 | -9.54% | Needham | $22 → $22 | Reiterates | Buy → Buy | |||
02/26/2025 | -9.54% | Piper Sandler | $21 → $22 | Maintains | Overweight | |||
02/26/2025 | -9.54% | Barclays | $23 → $22 | Maintains | Overweight | |||
12/12/2024 | -13.65% | Truist Securities | → $21 | Initiates | → Buy | |||
12/04/2024 | 2.8% | RBC Capital | $25 → $25 | Reiterates | Outperform → Outperform | |||
12/04/2024 | 2.8% | DA Davidson | $25 → $25 | Maintains | Buy | |||
12/04/2024 | 23.36% | Guggenheim | $30 → $30 | Reiterates | Buy → Buy | |||
12/04/2024 | -9.54% | Stifel | $20 → $22 | Maintains | Buy | |||
12/04/2024 | 2.8% | Morgan Stanley | $27 → $25 | Maintains | Equal-Weight | |||
12/04/2024 | 2.8% | Baird | $27 → $25 | Maintains | Outperform | |||
12/04/2024 | -9.54% | Needham | $22 → $22 | Maintains | Buy | |||
12/04/2024 | -13.65% | Piper Sandler | $21 → $21 | Maintains | Overweight | |||
11/15/2024 | -5.43% | Barclays | $19 → $23 | Maintains | Overweight | |||
10/07/2024 | -21.88% | Barclays | $19 → $19 | Upgrade | Equal-Weight → Overweight | |||
09/05/2024 | 2.8% | RBC Capital | $25 → $25 | Reiterates | Outperform → Outperform | |||
09/05/2024 | -5.43% | Wells Fargo | $30 → $23 | Maintains | Overweight | |||
09/05/2024 | -5.43% | Oppenheimer | $25 → $23 | Maintains | Outperform | |||
09/05/2024 | -21.88% | Barclays | $20 → $19 | Maintains | Equal-Weight | |||
09/05/2024 | 2.8% | DA Davidson | $30 → $25 | Maintains | Buy | |||
09/05/2024 | -17.76% | Stifel | $25 → $20 | Maintains | Buy | |||
09/05/2024 | -21.88% | UBS | $24 → $19 | Maintains | Neutral | |||
09/05/2024 | 11.02% | Morgan Stanley | $29 → $27 | Maintains | Equal-Weight | |||
09/05/2024 | 11.02% | Baird | $32 → $27 | Maintains | Outperform | |||
09/05/2024 | -9.54% | Needham | $22 → $22 | Reiterates | Buy → Buy | |||
09/05/2024 | -13.65% | Piper Sandler | $22 → $21 | Maintains | Overweight | |||
08/19/2024 | -17.76% | Barclays | $27 → $20 | Maintains | Equal-Weight | |||
08/16/2024 | -9.54% | Piper Sandler | → $22 | Initiates | → Overweight | |||
06/26/2024 | -9.54% | Needham | → $22 | Initiates | → Buy | |||
06/25/2024 | 23.36% | Guggenheim | $30 → $30 | Reiterates | Buy → Buy | |||
06/07/2024 | 23.36% | DA Davidson | $35 → $30 | Maintains | Buy | |||
06/06/2024 | 23.36% | Wells Fargo | $37 → $30 | Maintains | Overweight | |||
06/06/2024 | 11.02% | Barclays | $33 → $27 | Maintains | Equal-Weight | |||
06/06/2024 | 23.36% | Oppenheimer | $36 → $30 | Maintains | Outperform | |||
06/06/2024 | 19.24% | Morgan Stanley | $30 → $29 | Maintains | Equal-Weight | |||
06/06/2024 | -25.99% | Goldman Sachs | $30 → $18 | Downgrade | Neutral → Sell | |||
06/06/2024 | 31.58% | Baird | $35 → $32 | Maintains | Outperform | |||
06/06/2024 | 27.47% | RBC Capital | $35 → $31 | Maintains | Outperform | |||
05/22/2024 | 27.47% | UBS | → $31 | Initiates | → Neutral | |||
03/07/2024 | 23.36% | Goldman Sachs | $20 → $30 | Maintains | Neutral | |||
03/06/2024 | 43.91% | DA Davidson | $27 → $35 | Maintains | Buy | |||
03/06/2024 | 35.69% | Stifel | $24 → $33 | Maintains | Buy | |||
03/06/2024 | 43.91% | RBC Capital | $32 → $35 | Maintains | Outperform | |||
03/06/2024 | 48.03% | Oppenheimer | $25 → $36 | Maintains | Outperform | |||
03/06/2024 | 43.91% | Baird | $28 → $35 | Maintains | Outperform | |||
03/06/2024 | 35.69% | Barclays | $29 → $33 | Maintains | Equal-Weight | |||
03/06/2024 | 31.58% | Guggenheim | $27 → $32 | Maintains | Buy | |||
03/06/2024 | 52.14% | Wells Fargo | $34 → $37 | Maintains | Overweight | |||
03/05/2024 | 39.8% | Wells Fargo | $26 → $34 | Maintains | Overweight | |||
02/20/2024 | 19.24% | Barclays | $26 → $29 | Downgrade | Overweight → Equal-Weight | |||
01/12/2024 | 6.91% | Barclays | $23 → $26 | Maintains | Overweight | |||
12/14/2023 | 6.91% | RBC Capital | $26 → $26 | Reiterates | Outperform → Outperform | |||
12/11/2023 | -5.43% | Barclays | $21 → $23 | Maintains | Overweight | |||
12/07/2023 | -1.32% | Stifel | $22 → $24 | Maintains | Buy | |||
12/07/2023 | 6.91% | RBC Capital | $25 → $26 | Maintains | Outperform | |||
12/07/2023 | -13.65% | Morgan Stanley | $20 → $21 | Maintains | Equal-Weight | |||
09/13/2023 | 2.8% | RBC Capital | → $25 | Reiterates | Outperform → Outperform | |||
09/07/2023 | 2.8% | RBC Capital | → $25 | Reiterates | Outperform → Outperform | |||
08/18/2023 | -17.76% | Barclays | $23 → $20 | Maintains | Overweight | |||
06/07/2023 | -17.76% | Oppenheimer | → $20 | Reiterates | Outperform → Outperform | |||
06/07/2023 | -17.76% | Morgan Stanley | $19 → $20 | Maintains | Equal-Weight | |||
06/07/2023 | 2.8% | RBC Capital | → $25 | Reiterates | Outperform → Outperform | |||
06/07/2023 | -34.21% | Wedbush | → $16 | Reiterates | Neutral → Neutral | |||
06/07/2023 | -9.54% | Stifel | $19 → $22 | Maintains | Buy | |||
06/07/2023 | -5.43% | Baird | $20 → $23 | Maintains | Outperform | |||
06/07/2023 | -5.43% | Barclays | $19 → $23 | Maintains | Overweight | |||
06/05/2023 | 2.8% | RBC Capital | $20 → $25 | Maintains | Outperform | |||
03/08/2023 | -21.88% | Stifel | $17 → $19 | Maintains | Buy | |||
03/08/2023 | -17.76% | Baird | $18 → $20 | Maintains | Outperform | |||
03/08/2023 | -17.76% | Guggenheim | → $20 | Reiterates | → Buy | |||
03/08/2023 | -21.88% | Morgan Stanley | $18 → $19 | Maintains | Equal-Weight | |||
03/08/2023 | -17.76% | RBC Capital | $18 → $20 | Maintains | Outperform | |||
02/15/2023 | -21.88% | Barclays | $16 → $19 | Maintains | Overweight | |||
01/27/2023 | -17.76% | Guggenheim | → $20 | Initiates | → Buy |
FAQ
What is the target price for Couchbase (BASE) stock?
The latest price target for Couchbase (NASDAQ:BASE) was reported by Stifel on June 24, 2025. The analyst firm set a price target for $24.50 expecting BASE to rise to within 12 months (a possible 0.74% upside). 54 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Couchbase (BASE)?
The latest analyst rating for Couchbase (NASDAQ:BASE) was provided by Stifel, and Couchbase downgraded their hold rating.
When was the last upgrade for Couchbase (BASE)?
The last upgrade for Couchbase Inc happened on October 7, 2024 when Barclays raised their price target to $19. Barclays previously had an equal-weight for Couchbase Inc.
When was the last downgrade for Couchbase (BASE)?
The last downgrade for Couchbase Inc happened on June 24, 2025 when Stifel changed their price target from $22 to $24.5 for Couchbase Inc.
When is the next analyst rating going to be posted or updated for Couchbase (BASE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Couchbase, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Couchbase was filed on June 24, 2025 so you should expect the next rating to be made available sometime around June 24, 2026.
Is the Analyst Rating Couchbase (BASE) correct?
While ratings are subjective and will change, the latest Couchbase (BASE) rating was a downgraded with a price target of $22.00 to $24.50. The current price Couchbase (BASE) is trading at is $24.32, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
